Regulatory changes to the nursing home industry for this year may seem small individually, but together, they reflect broader initiatives sought by the ...
CareDx CDNA recently announced clinical validation data supporting AlloHeme, its next-generation, blood-based monitoring test designed to predict relapses in patients with acute myeloid leukemia (AML) ...
A novel blood based surveillance test using artificial intelligence and next-generation sequencing identified relapse a median of 41 days before clinical detection in patients with AML or MDS ...
Peer-reviewed Phase 2 Results Inform Ongoing Phase 3/Pivotal Trial of Celeste® in Parkinson’s Disease The Phase 2 study ...
The successful clinical validation of AlloHeme represents a key milestone in CareDx's Transplant+ strategy, expanding the Company's precision medicine capabilities into cell therapy, hematology, and ...
The two companies have inked a deal allowing Yatiri to identify biomarkers that could improve FHD-286's efficacy in advanced AML and MDS patients.
A major study led by the University of Hertfordshire has shown how linking care home data with NHS and social care records can improve residents' lives, strengthen policy decision-making and ensure ...
Detailed price information for Takeda Pharmaceutical Ltd ADR (TAK-N) from The Globe and Mail including charting and trades.
Poster to be presented at Tandem Meeting of the American Society of Transplantation and Cellular Therapy (ASTCT) and the Center for International ...
Building closer relationships with facility staff and health care partners of nursings homes, such as hospital providers and pharmacies, is going to be ...
Abstract: As cyclic codes and maximum distance separable (MDS) codes, cyclic MDS codes have very nice structures and properties, which have been intensively investigated in literature due to their ...
BMO’s new Blue Rewards program offers simpler, personalized perks and new partners for Canadian loyalty members this summer. Air Miles program members can continue to use their collector cards, and ...